Search PubMedSearch

PubMed · 8715021

Glaucoma: an overview.

Abstract

Glaucoma is one of the leading causes of blindness. It is a public health problem. No race is exempted from getting glaucoma. In the United States there are more than 2 million people afflicted with this disease. Every effort should be made to detect those people at risk early, and adequately manage them to prevent blindness. Therefore, it is important than an awareness of this disease should be created among health care professionals and the general public. This will lead to the early detection and proper management of this disease to prevent blindness. Glaucoma is a group of ocular conditions that will lead to blindness if it is not controlled. Although our knowledge about this group of diseases has advanced much in the past few decades--as compared with earlier times--we still are ignorant about the finer points and details regarding the disease. A lot of basic and clinical research is required to further and completely understand it. Much research is being done toward better management of glaucoma. Many multicenter clinical trials are being conducted. Collection of data regarding glaucoma is ongoing and will contribute to a better understanding of glaucoma--and thereby better management of patients who develop glaucoma.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

E Sivalingam. Glaucoma: an overview.. https://pubmed.ncbi.nlm.nih.gov/8715021/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Multiple cranial arteriovenous malformations in a child with eventual blindness in the affected eye.

PURPOSE: To report a case of multiple cranial arteriovenous malformations involving the orbit and retina. METHOD: Case report. We treated a 7-year-old girl who was diagnosed with a left submaxillary, a left retinal, a left orbital, and a middle subdural arteriovenous malformation. RESULTS: Enlargement of the arteriovenous malformations, except for the retinal arteriovenous malformation, was observed. After external carotid artery embolizations and radiation therapy for uncontrolled oral cavity bleeding, loss of light perception in the affected eye occurred, but no marked changes occurred in the retinal arteriovenous malformation. CONCLUSION: This rare case suggests that the clinical finding of a stable retinal arteriovenous malformation may be associated with enlargement of arteriovenous malformation lesions at other sites.

Blindness

Development of grating acuity in infants with Retinopathy of Prematurity.

PURPOSE: To evaluate the visual development in infants with stage 1 approximately 3 ROP and compare their visual results with healthy preterm infants. PATIENTS AND METHODS: One hundred forty-four premature infants were recruited and were divided into 3 groups according to the stage of ROP. Randomly selected preterm subjects with no ROP were taken as controls. Ophthalmic examinations started 4 to 7 weeks after birth and were repeated as needed until the retina was fully vascularized or until any ROP that developed had resolved. Grating acuity was measured by acuity cards between 35-45 weeks of corrected age and by PL method at 12, 18 and 24 months of age. RESULTS: Infants with stage 3 ROP had slightly lower visual acuity scores compared to other infants at most of the testing points throughout the 35-45 week period, which did not show statistical significance at any week. Infants with stage 2 and 3 ROP had similar visual acuity values but slightly lower acuity scores than infants with stage I or no ROP at the 12 month follow-up. The differences were not statistically significant. Stage 3 ROP infants had significantly lower acuity scores compared to infants with stage 1-2 or no ROP at the 18 and 24 month follow-up visits (p<0.0001). CONCLUSION: We stress periodic monitoring of early visual acuity in infants with ROP because of the possibility of impaired visual development.

Blindness